1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow PF-07263689: new trials by email Literature Review of PF-07263689 trials Research Report on PF-07263689
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors PF-07263689, Sasanlimab - Renal Cell Cancer, Melanoma | Phase 1 | Terminated | Pfizer | 13 | 2021-10-20 | 2024-04-12 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Liver Neoplasms (1) · Melanoma (1) · Ovarian Neoplasms (1) · Sarcoma (1) · Urinary Bladder Neoplasms (1)
Pfizer (1)
United States (1)